Dialysis Patients Develop Lower Antibody Response to Pfizer COVID-19 Vaccine

MONDAY, April 12, 2021 -- Most patients with kidney failure undergoing regular dialysis develop a substantial antibody response after receiving the Pfizer-BioNTech COVID-19 vaccine, according to a study published online April 6 in the Clinical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news